Literature DB >> 10989807

[Lifetime prevalence of mental disorders in general adult population. Results of TACOS study].

C Meyer1, H J Rumpf, U Hapke, H Dilling, U John.   

Abstract

The present paper reports lifetime prevalence rates of mental disorders in the 18- to 64-year-old general population of a northern German region. A representative random sample from registration office files of 4,075 individuals was examined in personal interviews using the fully standardized and computerised "Munich Composite International Diagnostic Interview" (M-CIDI). The response rate was 70.2%. Individuals were classified according to the DSM-IV. Substance use disorders were most frequent with 25.8% followed by anxiety (15.1%), somatoform (12.9%), affective (12.3%), and eating disorders (0.7%). Disorders other than substance use were more frequent in women and less frequent in men. A trend toward less psychiatric morbidity exists in individuals with higher educational level, higher income, and those who are married or reside in rural communities. Of all individuals affected by mental disorders, 42% fulfilled the criteria for at least one additional disorder. The results are discussed against the background of selected previous studies.

Entities:  

Mesh:

Year:  2000        PMID: 10989807     DOI: 10.1007/s001150050623

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  19 in total

1.  Prevalence of mental and social disorders in adults attending primary care centers in Bosnia and Herzegovina.

Authors:  Teresa Broers; Geoffrey Hodgetts; Olivera Batić-Mujanović; Verica Petrović; Melida Hasanagić; Marshall Godwin
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

Review 2.  [Risk factors for substance abuse and dependence in opioid therapy for chronic noncancer-related pain].

Authors:  J Jage; A Willweber-Strumpf; C Maier
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

Review 3.  [Forensic psychiatry in the era of neuroscience: present status and outlook for neurobiological research].

Authors:  J L Müller
Journal:  Nervenarzt       Date:  2009-03       Impact factor: 1.214

Review 4.  Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V.

Authors:  Katja Beesdo; Susanne Knappe; Daniel S Pine
Journal:  Psychiatr Clin North Am       Date:  2009-09

5.  Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.

Authors:  Anthony Wemakor; Karen Casson; Ester Garne; Marian Bakker; Marie-Claude Addor; Larraitz Arriola; Miriam Gatt; Babak Khoshnood; Kari Klungsoyr; Vera Nelen; Mary O'Mahoney; Anna Pierini; Anke Rissmann; David Tucker; Breidge Boyle; Lolkje de Jong-van den Berg; Helen Dolk
Journal:  Eur J Epidemiol       Date:  2015-07-07       Impact factor: 8.082

6.  Axis I disorders and personality disorders as risk factors for suicide.

Authors:  Barbara Schneider; Tilman Wetterling; Dieter Sargk; Fabian Schneider; Axel Schnabel; Konrad Maurer; Jürgen Fritze
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-08-30       Impact factor: 5.270

7.  [Prevalence of psychiatric disorders, psychopathology, and the need for treatment in female and male prisoners].

Authors:  C-E von Schönfeld; F Schneider; T Schröder; B Widmann; U Botthof; M Driessen
Journal:  Nervenarzt       Date:  2006-07       Impact factor: 1.214

Review 8.  [Psychiatric epidemiology and public health medicine. Principles of health service research].

Authors:  B T Baune; V Arolt
Journal:  Nervenarzt       Date:  2005-05       Impact factor: 1.214

9.  [Psychological abnormalities in patients with complex regional pain syndrome (CRPS)].

Authors:  O Rommel; A Willweber-Strumpf; P Wagner; D Surall; J-P Malin; M Zenz
Journal:  Schmerz       Date:  2005-08       Impact factor: 1.107

10.  The symptom checklist-27-plus (SCL-27-plus): a modern conceptualization of a traditional screening instrument.

Authors:  Jochen Hardt
Journal:  Psychosoc Med       Date:  2008-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.